Frederick Wittke

2.3k total citations · 1 hit paper
32 papers, 1.6k citations indexed

About

Frederick Wittke is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Frederick Wittke has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Frederick Wittke's work include Pneumonia and Respiratory Infections (8 papers), Streptococcal Infections and Treatments (7 papers) and Neonatal and Maternal Infections (6 papers). Frederick Wittke is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Streptococcal Infections and Treatments (7 papers) and Neonatal and Maternal Infections (6 papers). Frederick Wittke collaborates with scholars based in United States, Germany and Switzerland. Frederick Wittke's co-authors include Steffen Stenger, Clare Cutland, Karen S. Slobod, Peter Dull, Jan Buer, Jens Atzpodien, Arnold Ganser, Reinhard Hoffmann, Jacques Prandi and Lucia Mori and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Frederick Wittke

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data

2016 300 citations Flor M. Muñoz, Bernard Gonik et al. Vaccine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederick Wittke United States	19	588	573	391	265	222	32	1.6k
Karen Beckerman United States	15	312 0.5×	732 1.3×	254 0.6×	187 0.7×	70 0.3×	28	1.8k
Beth Holder United Kingdom	23	729 1.2×	608 1.1×	165 0.4×	503 1.9×	89 0.4×	48	2.0k
Archana Thomas United States	13	234 0.4×	227 0.4×	152 0.4×	182 0.7×	69 0.3×	27	906
Cyrille Bisseyé Gabon	21	618 1.1×	257 0.4×	455 1.2×	135 0.5×	73 0.3×	97	1.5k
Tao Shen China	21	514 0.9×	465 0.8×	174 0.4×	184 0.7×	93 0.4×	88	1.6k
Lena Serghides Canada	30	223 0.4×	912 1.6×	1.2k 3.1×	399 1.5×	205 0.9×	89	2.5k
J Wilczyński Poland	22	605 1.0×	403 0.7×	227 0.6×	154 0.6×	48 0.2×	116	1.5k
Robert Lorenz Chua Canada	15	344 0.6×	385 0.7×	187 0.5×	406 1.5×	250 1.1×	23	1.8k
Pere Soler‐Palacín Spain	22	558 0.9×	621 1.1×	176 0.5×	139 0.5×	57 0.3×	147	1.6k
Lynn S. Zijenah Zimbabwe	29	923 1.6×	569 1.0×	165 0.4×	302 1.1×	116 0.5×	67	3.0k

Countries citing papers authored by Frederick Wittke

Since Specialization

Citations

This map shows the geographic impact of Frederick Wittke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Wittke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Wittke more than expected).

Fields of papers citing papers by Frederick Wittke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Wittke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Wittke. The network helps show where Frederick Wittke may publish in the future.

Co-authorship network of co-authors of Frederick Wittke

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick Wittke. A scholar is included among the top collaborators of Frederick Wittke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick Wittke. Frederick Wittke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vélez, Juan D., Silvia Narejos Pérez, Rebecca A. Clark, et al.. (2025). A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10). Vaccines. 13(4). 341–341. 1 indexed citations

Goldblatt, David, Marion F. Gruber, Beate Kampmann, et al.. (2024). Realising the potential of correlates of protection for vaccine development, licensure and use: short summary. npj Vaccines. 9(1). 82–82. 18 indexed citations

Guerra, Andrea, et al.. (2023). Real-Time Monitoring of Infectious Disease Outbreaks with a Combination of Google Trends Search Results and the Moving Epidemic Method: A Respiratory Syncytial Virus Case Study. Tropical Medicine and Infectious Disease. 8(2). 75–75. 10 indexed citations

Benfield, Thomas, Piero Valentini, Ron Dagan, et al.. (2023). Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2). Vaccine. 41(15). 2456–2465. 15 indexed citations

Харит, С. М., et al.. (2021). Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents. Human Vaccines & Immunotherapeutics. 17(11). 4183–4189. 2 indexed citations

Wittke, Frederick, Catherine Vincent, James Chen, et al.. (2020). Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid. Antimicrobial Agents and Chemotherapy. 64(10). 42 indexed citations

Davis, Ian D., Tsin Yee Tai, Genevieve Whitty, et al.. (2017). A Pilot Study of Peripheral Blood BDCA-1 (CD1c) Positive Dendritic Cells Pulsed with NY-ESO-1 ISCOMATRIX™ Adjuvant. Immunotherapy. 9(3). 249–259. 14 indexed citations

Heyderman, Robert S., Shabir A. Madhi, Neil French, et al.. (2016). Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. The Lancet Infectious Diseases. 16(5). 546–555. 84 indexed citations

Muñoz, Flor M., Bernard Gonik, Clare Cutland, et al.. (2016). Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 34(49). 6047–6056. 300 indexed citations breakdown →

10.

Leroux‐Roels, Geert, Cathy Maes, Julie Willekens, et al.. (2016). A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women. Vaccine. 34(15). 1786–1791. 50 indexed citations

11.

Donders, Gilbert, Scott A. Halperin, Roland Devlieger, et al.. (2016). Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine. Obstetrics and Gynecology. 127(2). 213–221. 70 indexed citations

12.

Schümann, Jens, Frederick Wittke, Steffen Stenger, et al.. (2004). NK Cells, but Not NKT Cells, Are Involved in Pseudomonas aeruginosa Exotoxin A-Induced Hepatotoxicity in Mice. The Journal of Immunology. 172(5). 3034–3041. 64 indexed citations

13.

Gilleron, Martine, Steffen Stenger, Zaima Mazorra, et al.. (2004). Diacylated Sulfoglycolipids Are Novel Mycobacterial Antigens Stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis . The Journal of Experimental Medicine. 199(5). 649–659. 226 indexed citations

14.

Gansert, Jennifer, Frederick Wittke, Martin Röllinghoff, et al.. (2003). Human NKT Cells Express Granulysin and Exhibit Antimycobacterial Activity. The Journal of Immunology. 170(6). 3154–3161. 148 indexed citations

15.

Michel, Marc, Catherine Johanet, Olivier Meyer, et al.. (2001). Familial Lupus Erythematosus. Medicine. 80(3). 153–158. 66 indexed citations

16.

Michel, Marc, Olivier Meyer, Catherine Michel, et al.. (1999). Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. Arthritis & Rheumatism. 42(10). 2194–2197. 25 indexed citations

17.

Wittke, Frederick, Reinhard Hoffmann, Jan Buer, et al.. (1999). Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. British Journal of Cancer. 79(7-8). 1182–1184. 68 indexed citations

18.

Kirchner, Gabriele, Anke Franzke, Jan Buer, et al.. (1998). Pharmacokinetics of recombinant human interleukin‐2 in advanced renal cell carcinoma patients following subcutaneous application. British Journal of Clinical Pharmacology. 46(1). 5–10. 28 indexed citations

19.

Franzke, Anke, Michael Probst‐Kepper, Jan Buer, et al.. (1998). Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. British Journal of Cancer. 78(1). 40–45. 70 indexed citations

20.

Buer, Jan, M. Probst, Anke Franzke, et al.. (1997). Elevated serum levels of S100 and survival in metastatic malignant melanoma. British Journal of Cancer. 75(9). 1373–1376. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact